These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 16675319

  • 1. Potential for drug-drug interactions in patients taking analgesics for mild-to-moderate pain and low-dose aspirin for cardioprotection.
    Gaziano JM, Gibson CM.
    Am J Cardiol; 2006 May 08; 97(9A):23-9. PubMed ID: 16675319
    [Abstract] [Full Text] [Related]

  • 2. Gastrointestinal Considerations in Patients with Cardiovascular Disease Using Nonopioid Analgesics for Mild-to-Moderate Pain or Cardioprotection.
    Wilcox CM.
    Am J Cardiol; 2006 May 08; 97(9A):17-22. PubMed ID: 16675318
    [Abstract] [Full Text] [Related]

  • 3. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec 08; 16(92):223-7. PubMed ID: 18084859
    [Abstract] [Full Text] [Related]

  • 4. Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease.
    Whelton A.
    Am J Cardiol; 2006 May 08; 97(9A):3-9. PubMed ID: 16675316
    [Abstract] [Full Text] [Related]

  • 5. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
    Moyad MA.
    Semin Urol Oncol; 2001 Nov 08; 19(4):294-305. PubMed ID: 11769881
    [Abstract] [Full Text] [Related]

  • 6. Gastrointestinal safety of low-dose aspirin.
    Cryer B.
    Am J Manag Care; 2002 Dec 08; 8(22 Suppl):S701-8. PubMed ID: 12512737
    [Abstract] [Full Text] [Related]

  • 7. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E, Nedjar H.
    Rheumatology (Oxford); 2007 Mar 08; 46(3):435-8. PubMed ID: 17255138
    [Abstract] [Full Text] [Related]

  • 8. The use of NSAIDs in rheumatic disorders 2005: a global perspective.
    Kean WF, Buchanan WW.
    Inflammopharmacology; 2005 Mar 08; 13(4):343-70. PubMed ID: 16354389
    [Abstract] [Full Text] [Related]

  • 9. Forty years of ibuprofen use.
    Moore N.
    Int J Clin Pract Suppl; 2003 Apr 08; (135):28-31. PubMed ID: 12723744
    [Abstract] [Full Text] [Related]

  • 10. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks.
    Rostom A, Moayyedi P, Hunt R, Canadian Association of Gastroenterology Consensus Group.
    Aliment Pharmacol Ther; 2009 Mar 01; 29(5):481-96. PubMed ID: 19053986
    [Abstract] [Full Text] [Related]

  • 11. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM.
    Rev Cardiovasc Med; 2005 Mar 01; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [Abstract] [Full Text] [Related]

  • 12. [Combination therapy with acetylsalicylic acid and non-aspirin nonsteroidal anti-inflammatory drugs].
    Reuther LØ, Andersen SE.
    Ugeskr Laeger; 2006 Mar 27; 168(13):1310-4. PubMed ID: 16579883
    [Abstract] [Full Text] [Related]

  • 13. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
    Elnachef N, Scheiman JM, Fendrick AM, Howden CW, Chey WD.
    Aliment Pharmacol Ther; 2008 Nov 15; 28(10):1249-58. PubMed ID: 18729848
    [Abstract] [Full Text] [Related]

  • 14. The use and effect of analgesics in patients who regularly drink alcohol.
    Dart RC.
    Am J Manag Care; 2001 Dec 15; 7(19 Suppl):S597-601. PubMed ID: 11776482
    [Abstract] [Full Text] [Related]

  • 15. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
    Rahme E, Bardou M, Dasgupta K, Toubouti Y, Ghosn J, Barkun AN.
    Rheumatology (Oxford); 2007 Feb 15; 46(2):265-72. PubMed ID: 16844699
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
    Dajani EZ, Islam K.
    J Physiol Pharmacol; 2008 Aug 15; 59 Suppl 2():117-33. PubMed ID: 18812633
    [Abstract] [Full Text] [Related]

  • 17. Cardiovascular risks of cyclooxygenase inhibition.
    Stacy ZA, Dobesh PP, Trujillo TC.
    Pharmacotherapy; 2006 Jul 15; 26(7):919-38. PubMed ID: 16803424
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for adverse events in analgesic drug users: results from the PAIN study.
    Moore N, Charlesworth A, Van Ganse E, LeParc JM, Jones JK, Wall R, Schneid H, Verrière F.
    Pharmacoepidemiol Drug Saf; 2003 Jul 15; 12(7):601-10. PubMed ID: 14558184
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.